WBR0421: Difference between revisions

Jump to navigation Jump to search
No edit summary
YazanDaaboul (talk | contribs)
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}, {{AJL}} {{Alison}}
|QuestionAuthor={{YD}} (Reviewed by {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Biochemistry
|MainCategory=Biochemistry
Line 8: Line 8:
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Endocrine
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|MainCategory=Biochemistry
Line 20: Line 21:
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Endocrine
|Prompt=A 17-year-old female presents to the emergency room with complaints of chest pain and shortness of breath at rest. The patient takes atorvastatin for hypercholesterolemia and multiple members of her family died at a young age from myocardial infarction. Upon physical examination, you note tendon xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. Vital signs illustrate a temperature of 37 °C, heart rate of 102 beats per minute, and blood pressure of 110/70 mmHg. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads, elevation of tropnin I levels, and low density lipoprotein-cholesterol (LDL-C) levels of 980 mg/dL. Which of the following explains the pathogenesis of this patient’s disease?
|Prompt=A 38-year-old woman is brought to the emergency department for complaints of chest pain and shortness of breath at rest. She describes her pain as a crushing sensation in the middle of her chest that radiates to her left arm and is associated with nausea and cold sweats. The patient receives daily atorvastatin for hypercholesterolemia. She reports that multiple members of her family died at a young age from cardiovascular disease. On physical examination, the physician notes xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. In the ED, her temperature is 37.0 °C (98.6 °F), heart rate is 112/min, and blood pressure is 148/84 mmHg. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads. Her lab work-up is remarkable for elevation of troponin I and low-density lipoprotein-cholesterol (LDL-C) concentration of 680 mg/dL. The physician suspects that the patient's condition may be caused by an inherited disease. Which of the following explains the pathogenesis of this patient’s inherited disease?
 
|Explanation=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane commonly due to a mutation in ''LDLR'' gene in chromosome 19. The mutation results in abnormally elevated concentration of serum LDL-C due to decreased clearance of LDL-C at the level of the liver, which predisposes affected patients to accelerated [[atherosclerosis]] at a young age with an increased risk of early cardiovascular disease. Patients may present at young age (before the age of 50) with myocardial infarction along with signs of [[hypercholesterolemia]] on physical exam, such as [[Achilles tendon xanthoma]] and [[arcus senilis corneae]], as described in the patient in this vignette.  
|Explanation=[[Familial hypercholesterolemia]] (FH), an autosomal dominant disease characterized by the deficiency of [[LDL]] receptors on the hepatocytes plasma membrane, results from a mutation of LDLR gene on chromosome 19. The mutation results in abnormally elevated amounts of serum LDL due to decreased clearance of LDL at the level of the liver. Affected patients are predisposed to accelerated [[atherosclerosis]] and an increased risk of cardiovascular diseases, such as [[myocardial]] [[infarction]], and [[hypercholesterolemia]] manifesting upon physical exam as [[Achilles tendon xanthoma]] and [[arcus senilis corneae]].
FH occurs in both a homozygous and a heterozygous form.  The homozygous form, which is more severe, often manifests with LDL levels approximately 1000 mg/dL that are often refractory to anti-lipidemic medications and cardiovascular complications that frequently occur during childhood. In the heterozygous form, LDL levels are classically lower than that of homozygous FH, ranging from 300-500 mg/dL.  In patients with heterogeneous FH, who often do not display symptoms during childhood, the risk of atherosclerosis is elevated relative to the general population.
 
|EducationalObjectives= FH, an autosomal dominant disease resulting from a mutation of LDLR gene on chromosome 19, frequently leads to a deficiency or absence of LDL receptors on hepatocytes.  FH manifest with both a heterozygous and a more severe homozygous form.  FH may manifest with atherosclerosis in young individuals, as well as with signs of hypercholesterolemia, predisposing those affected to myocardial infarctions.
 
|References= Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989; Jan-Feb;9(1 Suppl):I3-7


|AnswerA=Increased hepatocyte production of LDL
FH has a homozygous form and a heterozygous form. The homozygous form is more severe; it occurs among patients who have 2 mutated alleles of the ''LDLR'' gene.  Classically, patients with homozygous mutation have LDL-C concentrations greater than 500 mg/dL that are often refractory to anti-lipidemic medications. These patients are also at high risk of early cardiovascular complications that may occur as early as adolescence or young adulthood. Heterozygous form develop when only 1 mutated allele is inherited. In the heterozygous form, LDL-C concentrations are classically lower than that of homozygous forms in the range of 300-500 mg/dL. In heterogeneous FH, cardiovascular disease may not manifest as early as homogeneous FH, but the risk of atherosclerosis is still high when compared with the general population.
|AnswerAExp=The increased hepatocytes production of LDL is not the pathogenesis of FH. LDL production is frequently increased secondary to insulin resistance, [[diabetes mellitus]], renal disease, and in obese individuals.
|AnswerA=Increased hepatocyte production of LDL-C
|AnswerAExp=The increased hepatocytes production of LDL-C is not the pathogenesis of FH. LDL production is frequently increased secondary to insulin resistance, [[diabetes mellitus]], renal disease, and in obese individuals.
|AnswerB=LDL-receptor overexpression
|AnswerB=LDL-receptor overexpression
|AnswerBExp=LDL receptor over-expression, occurring upon statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase, results in a reduced risk of  [[atherosclerosis]].
|AnswerBExp=LDL receptor over-expression occurs following initiation of statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase.
|AnswerC=Deficiency of high density lipoprotein (HDL)
|AnswerC=Deficiency of high density lipoprotein-cholesterol (HDL-C)
|AnswerCExp=Deficiency of HDL, frequently resulting from a genetic mutation of the ABC1 gene, may cause [[Tangier disease]] (TD) and some types of [[hypoalphalipoproteinemia]] (HA). HDL is considered an inverse predictor of [[atherosclerosis]].
|AnswerCExp=Deficiency of HDL-C frequently results from a genetic mutation in the ''ABC1'' gene and may cause [[Tangier disease]] (TD) and some types of [[hypoalphalipoproteinemia]] (HA). Classically, HDL-C concentration has been inversely associated with [[atherosclerosis]], but more recently, the emphasis of cardiovascular risk reduction shifted from the numerical concentration of HDL-C towards the function of HDL-C and ApoA-I given their capacity of reverse cholesterol transport.
|AnswerD=Deficiency of LDL receptors on hepatocyte plasma membrane
|AnswerD=Deficiency of LDL receptors on hepatocyte plasma membrane
|AnswerDExp=See explanation.  
|AnswerDExp=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane.
|AnswerEExp=Deficiency of lipoprotein lipase (LPL), characteristic of [[type I dyslipidemia]] ([[hyperchylomicronemia]]), manifests with elevated levels of circulating chylomicrons, resulting in elevated levels of triglycerides and cholesterol. A frequent complication of [[hyperchylomicronemia]] is recurrent [[pancreatitis]], not myocardial infarction.
|AnswerE=Deficiency of lipoprotein lipase (LPL)
|AnswerEExp=Deficiency of lipoprotein lipase (LPL) is type I dyslipidemia, called hyperchylomicronemia, which is characterized by elevated concentration of circulating chylomicrons that result in high concentration of triglycerides and cholesterol.   Although eruptive xanthoma may be present in hyperchylomicronemia, a classic complication of hyperchylomicronemia is usually recurrent pancreatitis (due to hypertriglyceridemia), not myocardial infarction.
|EducationalObjectives=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane commonly due to a mutation in ''LDLR'' gene in chromosome 19. Homozygous forms of FH may manifest with early atherosclerosis along with signs of hypercholesterolemia.
|References=Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989;9(1 Suppl):I3-7.<br>
First Aid 2014 page 87, 118
|RightAnswer=D
|RightAnswer=D
|WBRKeyword=LDL, familial hypercholesterolemia, myocardial, infarction, genetics, autosomal dominant, FH, inheritance
|WBRKeyword=LDL, Familial hypercholesterolemia, Myocardial infarction, Autosomal dominant, FH, Inheritance, Hypercholesterolemia,
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 17:31, 19 February 2015

 
Author [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Biochemistry
Sub Category SubCategory::Endocrine
Prompt [[Prompt::A 38-year-old woman is brought to the emergency department for complaints of chest pain and shortness of breath at rest. She describes her pain as a crushing sensation in the middle of her chest that radiates to her left arm and is associated with nausea and cold sweats. The patient receives daily atorvastatin for hypercholesterolemia. She reports that multiple members of her family died at a young age from cardiovascular disease. On physical examination, the physician notes xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. In the ED, her temperature is 37.0 °C (98.6 °F), heart rate is 112/min, and blood pressure is 148/84 mmHg. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads. Her lab work-up is remarkable for elevation of troponin I and low-density lipoprotein-cholesterol (LDL-C) concentration of 680 mg/dL. The physician suspects that the patient's condition may be caused by an inherited disease. Which of the following explains the pathogenesis of this patient’s inherited disease?]]
Answer A AnswerA::Increased hepatocyte production of LDL-C
Answer A Explanation [[AnswerAExp::The increased hepatocytes production of LDL-C is not the pathogenesis of FH. LDL production is frequently increased secondary to insulin resistance, diabetes mellitus, renal disease, and in obese individuals.]]
Answer B AnswerB::LDL-receptor overexpression
Answer B Explanation AnswerBExp::LDL receptor over-expression occurs following initiation of statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase.
Answer C AnswerC::Deficiency of high density lipoprotein-cholesterol (HDL-C)
Answer C Explanation [[AnswerCExp::Deficiency of HDL-C frequently results from a genetic mutation in the ABC1 gene and may cause Tangier disease (TD) and some types of hypoalphalipoproteinemia (HA). Classically, HDL-C concentration has been inversely associated with atherosclerosis, but more recently, the emphasis of cardiovascular risk reduction shifted from the numerical concentration of HDL-C towards the function of HDL-C and ApoA-I given their capacity of reverse cholesterol transport.]]
Answer D AnswerD::Deficiency of LDL receptors on hepatocyte plasma membrane
Answer D Explanation [[AnswerDExp::Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane.]]
Answer E AnswerE::Deficiency of lipoprotein lipase (LPL)
Answer E Explanation [[AnswerEExp::Deficiency of lipoprotein lipase (LPL) is type I dyslipidemia, called hyperchylomicronemia, which is characterized by elevated concentration of circulating chylomicrons that result in high concentration of triglycerides and cholesterol. Although eruptive xanthoma may be present in hyperchylomicronemia, a classic complication of hyperchylomicronemia is usually recurrent pancreatitis (due to hypertriglyceridemia), not myocardial infarction.]]
Right Answer RightAnswer::D
Explanation [[Explanation::Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane commonly due to a mutation in LDLR gene in chromosome 19. The mutation results in abnormally elevated concentration of serum LDL-C due to decreased clearance of LDL-C at the level of the liver, which predisposes affected patients to accelerated atherosclerosis at a young age with an increased risk of early cardiovascular disease. Patients may present at young age (before the age of 50) with myocardial infarction along with signs of hypercholesterolemia on physical exam, such as Achilles tendon xanthoma and arcus senilis corneae, as described in the patient in this vignette.

FH has a homozygous form and a heterozygous form. The homozygous form is more severe; it occurs among patients who have 2 mutated alleles of the LDLR gene. Classically, patients with homozygous mutation have LDL-C concentrations greater than 500 mg/dL that are often refractory to anti-lipidemic medications. These patients are also at high risk of early cardiovascular complications that may occur as early as adolescence or young adulthood. Heterozygous form develop when only 1 mutated allele is inherited. In the heterozygous form, LDL-C concentrations are classically lower than that of homozygous forms in the range of 300-500 mg/dL. In heterogeneous FH, cardiovascular disease may not manifest as early as homogeneous FH, but the risk of atherosclerosis is still high when compared with the general population.
Educational Objective: Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane commonly due to a mutation in LDLR gene in chromosome 19. Homozygous forms of FH may manifest with early atherosclerosis along with signs of hypercholesterolemia.
References: Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989;9(1 Suppl):I3-7.
First Aid 2014 page 87, 118]]

Approved Approved::Yes
Keyword WBRKeyword::LDL, WBRKeyword::Familial hypercholesterolemia, WBRKeyword::Myocardial infarction, WBRKeyword::Autosomal dominant, WBRKeyword::FH, WBRKeyword::Inheritance, WBRKeyword::Hypercholesterolemia
Linked Question Linked::
Order in Linked Questions LinkedOrder::